Clinical Updates on Newborn Screening and Disease Monitoring in Adrenoleukodystrophy

Clinical Updates on Newborn Screening and Disease Monitoring in Adrenoleukodystrophy is organized by PRIME Education, LLC, National Society of Genetic Counselors (NSGC).

Release Date: October 30, 2020
Expire Date: October 30, 2021

Accreditation:
Physician Credit Designation Statement:
PRIME® designates this Enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Interprofessional Teams:
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurse Practitioner Accreditation Statement:
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.5 contact hour (which includes 0.1 hour of pharmacology).

Pharmacist Accreditation Statement:
This Knowledge-based activity has been approved for 0.5 contact hour (0.05 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-20-085-H01-P. Pharmacy CE credits will be submitted electronically to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

Nurse Accreditation Statement:
PRIME® designates this activity for 0.5 contact hour.

Overview:
Adrenoleukodystrophy (ALD) places a devastating burden on patients and their families. Watch this webcast to hear patients and caregivers speak about the real-world impact of this disease and to learn about current and emerging therapies as well as the latest clinical updates in newborn screening and disease monitoring.